Norinchukin Bank The lifted its position in shares of Aetna Inc. (NYSE:AET) by 57.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,241 shares of the company’s stock after acquiring an additional 13,223 shares during the quarter. Norinchukin Bank The’s holdings in Aetna were worth $5,763,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Aetna by 2.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 268,088 shares of the company’s stock valued at $42,629,000 after acquiring an additional 6,615 shares during the period. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Aetna during the third quarter worth about $270,000. Meiji Yasuda Asset Management Co Ltd. boosted its position in shares of Aetna by 4.5% during the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 23,407 shares of the company’s stock worth $3,722,000 after buying an additional 1,000 shares during the period. Geneva Partners LLC acquired a new position in shares of Aetna during the third quarter worth about $1,170,000. Finally, Pacer Advisors Inc. boosted its position in shares of Aetna by 10.5% during the third quarter. Pacer Advisors Inc. now owns 7,360 shares of the company’s stock worth $1,170,000 after buying an additional 702 shares during the period. Institutional investors own 88.03% of the company’s stock.
Several research analysts have recently weighed in on AET shares. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective for the company in a research report on Thursday, October 12th. Jefferies Group upped their price objective on Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research report on Wednesday, November 1st. BMO Capital Markets started coverage on Aetna in a research report on Monday, October 16th. They set a “market perform” rating and a $175.00 price objective for the company. Raymond James Financial upgraded Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price on the stock in a report on Friday, November 3rd. Finally, Credit Suisse Group reiterated a “neutral” rating and set a $195.00 target price (up previously from $174.00) on shares of Aetna in a report on Wednesday. Twelve research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $175.19.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.
Aetna Inc. (NYSE AET) opened at $178.83 on Friday. Aetna Inc. has a 12-month low of $116.04 and a 12-month high of $192.37. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The company has a market capitalization of $58,283.73, a P/E ratio of 17.50, a PEG ratio of 1.63 and a beta of 0.61.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. During the same quarter in the prior year, the business earned $2.07 earnings per share. The firm’s revenue for the quarter was down 5.0% on a year-over-year basis. sell-side analysts expect that Aetna Inc. will post 9.78 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.12%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s payout ratio is 37.04%.
WARNING: “Aetna Inc. (NYSE:AET) Shares Bought by Norinchukin Bank The” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/08/norinchukin-bank-the-purchases-13223-shares-of-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.